Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
or

Medexus Pharmaceuticals Inc (MEDXF)

Medexus Pharmaceuticals Inc (MEDXF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
1.5250 +0.0070 (+0.46%) 04/07/25 [OTC US]
N/A x N/A N/A x N/A
Post-market 1.5250 unch (unch) 14:32 ET
Quote Overview for Mon, Apr 7th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.4300
Day High
1.5800
Open 1.4500
Previous Close 1.5180 1.5180
Volume 15,600 15,600
Avg Vol 10,970 10,970
Stochastic %K 19.38% 19.38%
Weighted Alpha +8.30 +8.30
5-Day Change -0.1350 (-8.13%) -0.1350 (-8.13%)
52-Week Range 1.0800 - 3.8800 1.0800 - 3.8800
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.4300 +6.64%
on 04/07/25
Period Open: 1.8500
1.9795 -22.96%
on 03/20/25
-0.3250 (-17.57%)
since 03/07/25
3-Month
1.4300 +6.64%
on 04/07/25
Period Open: 2.3990
3.8800 -60.70%
on 01/22/25
-0.8740 (-36.43%)
since 01/07/25
52-Week
1.0800 +41.20%
on 04/18/24
Period Open: 1.1800
3.8800 -60.70%
on 01/22/25
+0.3450 (+29.24%)
since 04/05/24

Most Recent Stories

More News
Medexus Provides Update on Progress of Commercialization of GRAFAPEX (treosulfan) for Injection

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - April 7, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to provide a business update on the progress of the commercial launch...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus Completes Agreement to Return US Commercialization Rights for Gleolan to NX Development Corp.

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 14, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed an agreement with NX Development Corp., the licensor of...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus Announces Commercial Availability of GRAFAPEX (treosulfan) for Injection

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 24, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that GRAFAPEXâ„¢ (treosulfan) for Injection is now...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus Announces Strong Fiscal Q3 2025 Results, Well-Positioned to Launch GRAFAPEX (treosulfan) for Injection in the United States

Fiscal Q3 2025 revenue of $30.0 million, net income of $0.7 million, operating income of $3.8 million, and Adjusted EBITDA* of $5.8 millionManagement to host conference call at 8:00 AM Eastern time on...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus and Ontario's Provincial Health Services Successfully Complete Agreements for Public Reimbursement of Trecondyv (treosulfan for injection) in Ontario, Canada

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - February 4, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed listing agreements with Ontario's Ministry of Health (Ontario...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus Schedules Third Fiscal Quarter 2025 Conference Call

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 31, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) plans to host a conference call at 8:00 am Eastern Time on Thursday, February...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus Announces FDA Approval of GRAFAPEX (treosulfan) for Injection and Provides Business Update

Medexus will target a commercial launch in 1H CY2025; potential for annual product-level revenue to exceed US$100 million within five years after commercial launchToronto, Ontario and Chicago, Illinois--(Newsfile...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus and British Columbia's Provincial Health Services Authority (PHSA) Successfully Complete Agreement for Public Reimbursement of Trecondyv (treosulfan for injection) in British Columbia, Canada

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - January 15, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed a listing agreement with British Columbia's Provincial...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus and medac Conclude Negotiations to Amend US Treosulfan Agreement, Setting Regulatory Milestone Amounts and Payment Schedule

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - December 2, 2024) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the company recently entered into a fourth amendment...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)
Medexus and pan-Canadian Pharmaceutical Alliance (pCPA) Successfully Complete Negotiations for Trecondyv (treosulfan for injection) in Canada

Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - November 18, 2024) - Earlier in November 2024, Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) successfully completed a negotiation process with...

MEDXF : 1.5250 (+0.46%)
MDP.TO : 2.17 (+0.93%)

Key Turning Points

3rd Resistance Point 1.7433
2nd Resistance Point 1.6617
1st Resistance Point 1.5933
Last Price 1.5250
1st Support Level 1.4433
2nd Support Level 1.3617
3rd Support Level 1.2933

See More

52-Week High 3.8800
Fibonacci 61.8% 2.8104
Fibonacci 50% 2.4800
Fibonacci 38.2% 2.1496
Last Price 1.5250
52-Week Low 1.0800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Trader's Cheat Sheet: Your Secret Weapon for Smarter Trades